Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients

Objectives: The aim of this study is to evaluate the efficacy and the safety of Sanyak pharmacopuncture therapy for the treatment of peripheral facial paralysis patients. Methods: This study was a retrospective investigation of a total of 70 patients who were inpatients of the Oriental Hospital of...

Full description

Bibliographic Details
Main Authors: Sung In-Soo, Hong Kwon-eui, Kim Min-Jung, Song In
Format: Article
Language:English
Published: Korean Pharmacopuncture Institute 2012-12-01
Series:Journal of Pharmacopuncture
Subjects:
Online Access:http://dx.doi.org/10.3831/KPI.2012.15.010
id doaj-15a60e319cba434e8a4b548f1947684d
record_format Article
spelling doaj-15a60e319cba434e8a4b548f1947684d2020-11-25T02:12:27ZengKorean Pharmacopuncture InstituteJournal of Pharmacopuncture2093-69662234-68562012-12-01154152410.3831/KPI.2012.15.010Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients Sung In-Soo 0Hong Kwon-eui 1Kim Min-Jung 2Song In 3Department of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, KoreaDepartment of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, KoreaDepartment of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, KoreaDepartment of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, KoreaObjectives: The aim of this study is to evaluate the efficacy and the safety of Sanyak pharmacopuncture therapy for the treatment of peripheral facial paralysis patients. Methods: This study was a retrospective investigation of a total of 70 patients who were inpatients of the Oriental Hospital of Daejeon University between January 1, 2011, and May 31, 2012, and who were diagnosed as having peripheral facial paralysis by physical examination, the patients received three different interventions. Eleven (11) patients were treated with acupuncture and alcohol Dioscorea rhizoma pharmacopuncture (ADG), 25 patients with acupuncture and distillation Dioscorea rhizoma pharmacopuncture (DDG), and 34 patients with acupuncture and non-Dioscorea rhizoma pharmacopuncture (NDG). The resulting data were analyzed. Results: The changed H-B grades indicated significant improvements in all three groups, and the ADG and the DDG groups showed significant results after two weeks of treatment when compared to the NDG group. The changed y-Scores indicated significant improvements in all three groups, and the ADG group showed significant results after 10 and 15 days of treatment when compared to the NDG group. Dioscorea rhizoma pharmacopuncture may be safe for the human body because in most cases, the only abnormal finding was the pain could by the application of pharmacopuncture. Conclusions: The results of this study suggest that Oriental medical treatment with dioscoreae Rhizoma (Sanyak) pharmacopuncture complex therapy may be effective and safe in patient with peripheral facial paralysis http://dx.doi.org/10.3831/KPI.2012.15.010Dioscoreae Rhizoma pharmacopuncturegross grading system of House-Brackmannperipheral facial paralysisYanagihara's unweighted grading system
collection DOAJ
language English
format Article
sources DOAJ
author Sung In-Soo
Hong Kwon-eui
Kim Min-Jung
Song In
spellingShingle Sung In-Soo
Hong Kwon-eui
Kim Min-Jung
Song In
Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
Journal of Pharmacopuncture
Dioscoreae Rhizoma pharmacopuncture
gross grading system of House-Brackmann
peripheral facial paralysis
Yanagihara's unweighted grading system
author_facet Sung In-Soo
Hong Kwon-eui
Kim Min-Jung
Song In
author_sort Sung In-Soo
title Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
title_short Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
title_full Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
title_fullStr Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
title_full_unstemmed Clinical Research of the Efficacy and the Safety of Dioscoreae Rhizoma (Sanyak) Pharmacopuncture Therapy for Peripheral Facial Paralysis Patients
title_sort clinical research of the efficacy and the safety of dioscoreae rhizoma (sanyak) pharmacopuncture therapy for peripheral facial paralysis patients
publisher Korean Pharmacopuncture Institute
series Journal of Pharmacopuncture
issn 2093-6966
2234-6856
publishDate 2012-12-01
description Objectives: The aim of this study is to evaluate the efficacy and the safety of Sanyak pharmacopuncture therapy for the treatment of peripheral facial paralysis patients. Methods: This study was a retrospective investigation of a total of 70 patients who were inpatients of the Oriental Hospital of Daejeon University between January 1, 2011, and May 31, 2012, and who were diagnosed as having peripheral facial paralysis by physical examination, the patients received three different interventions. Eleven (11) patients were treated with acupuncture and alcohol Dioscorea rhizoma pharmacopuncture (ADG), 25 patients with acupuncture and distillation Dioscorea rhizoma pharmacopuncture (DDG), and 34 patients with acupuncture and non-Dioscorea rhizoma pharmacopuncture (NDG). The resulting data were analyzed. Results: The changed H-B grades indicated significant improvements in all three groups, and the ADG and the DDG groups showed significant results after two weeks of treatment when compared to the NDG group. The changed y-Scores indicated significant improvements in all three groups, and the ADG group showed significant results after 10 and 15 days of treatment when compared to the NDG group. Dioscorea rhizoma pharmacopuncture may be safe for the human body because in most cases, the only abnormal finding was the pain could by the application of pharmacopuncture. Conclusions: The results of this study suggest that Oriental medical treatment with dioscoreae Rhizoma (Sanyak) pharmacopuncture complex therapy may be effective and safe in patient with peripheral facial paralysis
topic Dioscoreae Rhizoma pharmacopuncture
gross grading system of House-Brackmann
peripheral facial paralysis
Yanagihara's unweighted grading system
url http://dx.doi.org/10.3831/KPI.2012.15.010
work_keys_str_mv AT sunginsoo clinicalresearchoftheefficacyandthesafetyofdioscoreaerhizomasanyakpharmacopuncturetherapyforperipheralfacialparalysispatients
AT hongkwoneui clinicalresearchoftheefficacyandthesafetyofdioscoreaerhizomasanyakpharmacopuncturetherapyforperipheralfacialparalysispatients
AT kimminjung clinicalresearchoftheefficacyandthesafetyofdioscoreaerhizomasanyakpharmacopuncturetherapyforperipheralfacialparalysispatients
AT songin clinicalresearchoftheefficacyandthesafetyofdioscoreaerhizomasanyakpharmacopuncturetherapyforperipheralfacialparalysispatients
_version_ 1724909227359600640